首页> 美国卫生研究院文献>BMC Cancer >Low salivary testosterone levels in patients with breast cancer

【2h】

Low salivary testosterone levels in patients with breast cancer

机译：乳腺癌患者唾液睾丸激素水平低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundCorrelation between circulating sex steroid levels and breast cancer has been controversial, with measurement of free, or bioavailable hormone rarely available. Salivary hormone levels represent the bioavailable fraction. To further elucidate the role of endogenous hormones in breast cancer, we aimed to assess correlation between salivary sex steroid levels and breast cancer prevalence.

机译：背景循环性类固醇水平与乳腺癌之间的相关性一直存在争议，其中游离激素或可生物利用激素的测定很少。唾液激素水平代表生物利用度。为了进一步阐明内源性激素在乳腺癌中的作用，我们旨在评估唾液性类固醇水平与乳腺癌患病率之间的相关性。

著录项

期刊名称 BMC Cancer
作者
Constantine Dimitrakakis; David Zava; Spyros Marinopoulos; Alexandra Tsigginou; Aris Antsaklis; Rebecca Glaser;
展开▼
作者单位

展开▼
年(卷),期 2010(10),-1
年度 2010
页码 547
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Low salivary testosterone levels in patients with breast cancer [J] . Constantine Dimitrakakis, David Zava, Spyros Marinopoulos, BMC Cancer . 2010,第1期

机译：乳腺癌患者唾液睾丸激素水平低
2. Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients [J] . Coradini Danila, Orenti Annalisa, Venturelli Elisabetta, Japanese journal of clinical oncology. . 2018,第4期

机译：血清睾酮和SHBG与体重指数相关的血清水平提高了巩固肿瘤生物标志物在预期和绝经后乳腺癌患者中的预测能力
3. Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy [J] . Giorgio Secreto, Paola Muti, Milena Sant, Endocrine-related cancer . 2017,第11期

机译：睾丸激素水平高的更年期乳腺癌患者的医疗卵巢切除术：朝着量身定制的治疗迈进的一步
4. Results of treatment of the patients with II~(nd)-III~(rd) st. breast cancer by combination of low level laer therapy (LLLT) and surgery (10-year experience) [C] . V.A.Mikhailov, I.N.Densiov, G.A.Frank, Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：II〜（nd）-III〜（rd）st患者的治疗结果。低水平激光疗法（LLLT）和手术相结合的乳腺癌（10年经验）
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors [O] . David T Zava, David W Kimball, Rebecca L Glaser 2021

机译：用睾酮颗粒治疗的乳腺癌患者LC-MS / MS唾液雌激素和芳香酶抑制剂与亚甘露酶抑制剂合并
7. Low salivary testosterone levels in patients with breast cancer [O] . Tsigginou Alexandra, Marinopoulos Spyros, Zava David, 2010

机译：乳腺癌患者唾液睾丸激素水平低

Low salivary testosterone levels in patients with breast cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅